首页> 外文OA文献 >Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma

【2h】

Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma

机译：患者和肿瘤生物学预测肝细胞癌肝移植的存活率超出米兰标准

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andreou Andreas; Gül Safak; Pascher Andreas; Schöning Wenzel; Al‐Abadi Hussein; Bahra Marcus; Klein Fritz; Denecke Timm; Strücker Benjamin; Puhl Gero; Pratschke Johann; Seehofer Daniel;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma [J] . Andreou Andreas, Guel Safak, Pascher Andreas, HPB: the official journal of the International Hepato Pancreato Biliary Association . 2015,第2期

机译：患者和肿瘤生物学预测肝细胞癌肝移植的存活率超出米兰标准
2. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria. [J] . Sieghart W, Wang X, Schmid K, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2011,第1期

机译：骨桥蛋白的表达预测肝移植后米兰患者肝癌的总体存活率超出米兰标准。
3. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. [J] . Mazzaferro V, Llovet JM, Miceli R, The lancet oncology . 2009,第1期

机译：超出米兰标准的肝细胞癌患者肝移植后的生存预测：一项回顾性，探索性分析。
4. Kinetic Textural Biomarker for Predicting Survival of Patients with Advanced Hepatocellular Carcinoma After Antiangiogenic Therapy by Use of Baseline First-Pass Perfusion CT [C] . Sang Ho Lee, Koichi Hayano, Dushyant V. Sahani, International conference on medical image computing and computer-assisted intervention;International workshop on abdominal imaging: computational and clinical applications . 2014

机译：动力学纹理生物标志物通过基线首过灌注CT预测抗血管生成治疗后晚期肝细胞癌患者的生存率
5. Macrotrabecular Massive, a Novel Hepatocellular Carcinoma Histological Subtype: Analysis of Post- Resection and Transplant Recurrence [D] . Jeon, Yejoo. 2019

机译：Macrootrabular巨大，一种新型肝细胞癌组织学亚型：分析切除后和移植复发
6. Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma [O] . Andreas Andreou, Safak Gül, Andreas Pascher, 2015

机译：患者和肿瘤生物学预测肝细胞癌肝移植的存活率超出米兰标准
7. Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand [O] . Chen, John WC, Kow, Lilian, Verran, Deborah J, 2009

机译：移植肝细胞癌（HCC）超过Milan或UCSF标准的患者的生存期较差。澳大利亚和新西兰肝癌肝移植分析

Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅